Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine

Journal of Drug Delivery Science and Technology

Volumn 22, Issue 2, 2012, Pages 125-130

  Battaglia, L ^a   D'Addino, I ^a   Peira, E ^a   Trotta, M ^a   Gallarate, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Coacervation; Cyclosporine; Ocular administration; SLN

Indexed keywords

CHITOSAN; CYCLOSPORIN A; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CHEMICAL STRUCTURE; COACERVATION; CONTROLLED STUDY; CORNEA; CORNEA OPACITY; CORNEA PERMEABILITY; DRUG ACCUMULATION; DRUG FORMULATION; DRUG PENETRATION; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; SURFACE CHARGE; ZETA POTENTIAL;

EID: 84859632374     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(12)50016-X     Document Type: Article

References (28)

1. Ridder III W.H. - Cyclosporin use in dry eye disease patients. - Expert Opin. Pharmacother., 9, 3121-3128, 2009.
2. Donnenfeld E., Pflugfelder S.C. - Topical ophthalmic cyclosporine: pharmacology and clinical uses. - Surv. Ophtalmol., 54, 321-338, 2009.
3. Foulks G.N. - Topical cyclosporine for treatment of ocular surface disease. - Int. Ophthalmol. Clin., 46, 105-122, 2007.
4. Sahoo S.K., Dilnawaz F., Krishnakumar S. - Nanotechnology in ocular drug delivery. - Drug Discov. Today, 13, 144-151, 2008.
5. Nagarwal R.C., Kant S., Singh P.N., Maiti P., Pandit J.K. - Polymeric nanoparticulate system: a potential approach for ocular drug delivery. - J. Contrail Release, 136, 2-13, 2009.
6. Müller R.H., Mäder K., Gohla S. - Solid lipid nanoparticles (SLN) for controlled drug delivery, a review of the state of the art. - Eur. J. Pharm. Biopharm., 50, 161-177, 2000. (Pubitemid 30326695)
7. Attama A.A., Reicht S., Mueller-Goymann C.C. - Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. - Curr. Eye Res., 34, 698-705, 2009.
8. Attama A.A., Reichl S., Mueller-Goymann C.C. - Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. - Int. J. Pharm., 355, 307-313, 2008.
9. Battaglia L., Gallarate M., Cavalli R., Trotta M. - Solid lipid nanoparticles produced through a coacervation method. - J. Microencaps., 27, 78-85, 2010.
10. Gallarate M., Trotta M., Battaglia L., Chirio D. - Cisplatin loaded SLN produced by coacervation technique. - J. Drug Del. Sci. Tech., 20, 343-347, 2010.
11. Chen Y., Mohanrajand V.J., Parkin J.E. - Chitosan dextran sulfate nanoparticles for delivery of an anti-angiogenetis peptide. - Lett. Peptide Sci., 10, 621-629, 2003. (Pubitemid 40379055)
12. Merodio M., Armedo A. Renedo M.J., Irache J.M. - Ganciclovir loaded albumin nanoparticles: characterisation and in vitro release properties. - Eur. J. Pharm. Sci., 12, 251-259, 2001.
13. Wilhelmus K.R. - The draize eye test. - Surv. Ophtalmol., 45, 493-515, 2001.
14. Wiederholt M., Kossendrup D., Schulz W., Hoffmann F. - Pharmacokinetic of topical cyclosporin A in the rabbit eye. - Invest. Ophthalmol. Vis. Sci., 4, 519-524, 1986. (Pubitemid 16116297)
15. Camber O. - An in vitro model for determination of drug permeability through the cornea. - Acta Pharm. Suec., 22, 335-342, 1985. (Pubitemid 16184699)
16. Steinhardt R.A. - Cornea preservation medium. - US Patent 7087369, 17 december 2003.
17. Istruzione tecnica per il prelievo delle cornee. - Banca delle cornee della regione Piemonte, Co 18.7/2006.
18. Casterton P.L., Potts L.F., Klein B.D. - A novel approach to assessing eye irritation potential using the bovine corneal opacity and permeability assay. - J. Toxicol. Cutan. Ocul. Toxicol., 15, 147-163, 1996. (Pubitemid 26117130)
19. Ubels J.L., Ditlev J.A., Clousing D.P., Casterton P.L. - Corneal permeability in a redesigned corneal holder for the bovine cornea opacity and permeability assay. - Toxicol, in vitro, 18, 853-857, 2004. (Pubitemid 39311898)
20. Fois R.A., Ashley J.J. - Synthesis of a fluorescent derivate of cyclosporin A for high-performance liquid chromatography analysis. - J. Pharm. Sci., 80, 363-367, 1991.
21. Rüegger A., Kuhn M., Lichti H., Loosli H.R., Huguenin R., Quiquerez C., von Wartburg A. - Cyclosporin A, ein immunsuppressiv wirksamer peptid metabolit aus Trichoderma Polysporum Rifai. - Helv. Chim. Acta, 59, 1075-1092, 1976.
22. Qaqish R.B., Amiji M.M. - Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. - Carbohyd. Polym., 38, 99-107, 1999.
23. Ubels J.L., Pruis R.M., Sybesma J.T., Casterton P.L. - Corneal opacity, hydration and endothelial morphology in the bovine cornea opacity and permeability assay using reduced treatment times. - Toxicol. in vitro, 14, 379-386, 2000. (Pubitemid 30440605)
24. Gautheron P.D., Dukic M., Alix D., Sina J.F. - Bovine cornea opacity and permeability test: an in vitro assay of ocular irritancy. - Fund. Appl. Toxicol., 18, 442-449, 1992.
25. Hung-Hong Lin, Shiu-Man Ko, Li-Ren Hsu, Yi-Hung Tsai. - The preparation of norfloxacin-loaded liposomes and their in vitro evaluation in pig's eye. - J. Pharm. Pharmacol., 48, 801-805, 1996.
26. Kumar M.N., Mohapatra S.S., Kang X, Jena P.K., Bakawsky U., Lehr C.M. - Cationic poly(lectide-co-glicolide) nanoparticles as efficient in vivo gene transfection. - J. Nanosci. Nanotechnol., 4, 990-994, 2004. (Pubitemid 40056457)
27. Alonso M.J., Sanchez A. - The potential of chitosan in ocular drug delivery. - J. Pharm. Pharmacol., 55, 1451-1463, 2003. (Pubitemid 37441350)
28. Barile F.A. - Validating and troubleshooting ocular in vitro toxicology tests. - J. Pharmacol. Toxicol. Meth., 61, 1136-145, 2010.